A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy
Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, two-stage, phase II clinical study .The main objective is
to evaluate the safety and tolerability of HSK21542 injection for analgesia in patients
undergoing colonoscopy, and, combining the pharmacodynamic (PD) and pharmacokinetic (PK)
characteristics
Phase:
Phase 2
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd. Sichuan Haisco Pharmaceutical Group Co., Ltd.